CDNA · CareDx, Inc. · Executive Compensation
$88.92
+3.04 (+3.54%)
At close · Nov 3
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$4.51B
Shares
52.54M
Volume · Nov 3
1.59M
Avg daily vol (3M)
1.3M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John W. Hanna | President and Chief Executive Officer | $7,179,699 |
| Keith Kennedy | Chief Operating Officer and Chief Financial Officer | $3,219,231 |
| Abhishek Jain | Former Chief Financial Officer | $2,637,934 |
| Jessica Meng | Chief Commercial Officer | $2,579,380 |
| Jeffrey Novack | General Counsel and Secretary | $1,239,552 |
| Nathan Smith | Former Chief Financial Officer | $967,959 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John W. Hanna | President and Chief Executive Officer | $9,424,329 |
| Keith Kennedy | Chief Operating Officer and Chief Financial Officer | $4,512,215 |
| Jessica Meng | Chief Commercial Officer | $3,392,528 |
| Abhishek Jain | Former Chief Financial Officer | $2,762,710 |
| Jeffrey Novack | General Counsel and Secretary | $1,276,844 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Abhishek Jain | Former Chief Financial Officer | $3,094,707 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Reginald Seeto | MBBS Chief Executive Officer and President | $7,090,121 |
| Alex Johnson | Chief Business Officer | $3,967,447 |
| Ankur Dhingra | Chief Financial Officer | $3,266,985 |
| Peter Maag | Ph.D., Former Executive Chair | $3,209,282 |
| Sasha King | Chief Marketing Officer | $1,904,888 |
| Marcel Konrad | Former Interim Chief Financial Officer | $679,892 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Peter Maag | Ph.D., Former Executive Chair | $6,400,015 |
| Reginald Seeto | MBBS Chief Executive Officer and President | $5,618,698 |
| Michael Bell | Former Chief Financial Officer | $3,443,952 |
| Sasha King | Chief Marketing Officer | $1,541,104 |
| Marcel Konrad | Former Interim Chief Financial Officer | $953,469 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Peter Maag | Ph.D., Former Executive Chair | $9,424,083 |
| Michael Bell | Former Chief Financial Officer | $2,685,687 |
| Reginald Seeto | MBBS Chief Executive Officer and President | $1,955,661 |
| Sasha King | Chief Marketing Officer | $1,508,750 |
| James P. Yee | M.D., Ph.D. Former Chief Medical Officer | $1,178,227 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Peter Maag | Ph.D., Executive Chair and Former Chief Executive Officer | $5,231,391 |
| Reginald Seeto | MBBS Chief Executive Officer, President and Chief Business Officer | $3,168,380 |
| Michael Bell | Former Chief Financial Officer | $2,095,009 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Peter Maag | Ph.D., Chairman and Chief Executive Officer | $1,401,297 |
| Michael Bell | Chief Financial Officer | $690,760 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John W. Hanna | Class III director | Appointed | 2026-06-15 |
| Suresh Gunasekaran | Class II director | Appointed | 2026-06-15 |
| Michael D. Goldberg | Class III director | Appointed | 2026-06-15 |
| R. Bryan Riggsbee | Class II director | Appointed | 2026-06-15 |
| Fred E. Cohen, M.D., D. Phil | Class II director | Appointed | 2026-06-15 |
| Suresh Gunasekaran | Class II director | Appointed | 2025-10-24 |
| Abhishek Jain | Chief Financial Officer | Retired | 2025-08-06 |
| Nathan Smith | Chief Financial Officer | Appointed | 2025-08-06 |
| R. Bryan Riggsbee | Class II director | Appointed | 2025-06-12 |
| Fred E. Cohen, M.D., D. Phil | Class II director | Appointed | 2025-06-12 |
| Alexander Johnson | President of Patient and Testing Services | Terminated | 2024-10-04 |
| Marica Grskovic | Chief Strategy Officer | Appointed | 2024-09-12 |
| Jessica Meng | Chief Commercial Officer | Appointed | 2024-09-12 |
| Keith Kennedy | Chief Operating Officer | Appointed | 2024-09-12 |
| Alexander Johnson | President of Patient and Testing Services | Terminated | 2024-09-12 |
| Keith Kennedy | Chief Operating Officer | Appointed | 2024-09-12 |
| John W. Hanna | Class III director | Appointed | 2024-04-16 |
| John W. Hanna | President and Chief Executive Officer | Appointed | 2024-04-16 |
| R. Bryan Riggsbee | Chairperson of the Audit and Finance Committee | Appointed | 2024-03-11 |
| R. Bryan Riggsbee | Class II director | Appointed | 2024-03-11 |
| Alexander L. Johnson | principal executive officer | Appointed | 2023-11-01 |
| Reginald Seeto, MBBS | Board | Resigned | 2023-11-01 |
| Reginald Seeto, MBBS | President and Chief Executive Officer | Resigned | 2023-11-01 |
| Abraham Ronai | Chief Administrative & Legal Officer and Secretary | Resigned | 2023-09-26 |
| Ralph Snyderman, M.D. | Board | Resigned | 2022-11-23 |
Leadership
- Alexander L. Johnson CEO
- John W. Hanna CEO, Board Member
- Michael D. Goldberg Chairman, Board Member
- Peter Maag, Ph.D. Chairman
- Abhishek Jain CFO
- Keith Kennedy CFO, COO
- Nathan Smith CFO
- Abraham Ronai General Counsel
- Jeffrey Novack General Counsel
- Arthur A. Torres Board Member
- Christine M. Cournoyer Board Member
- Continuing Directors Board Member
- Directors with Terms Expiring Board Member
- Fred E. Cohen Board Member
- Fred E. Cohen, M.D., D. Phil Board Member
- George W. Bickerstaff Board Member
- Hannah A. Valantine Board Member
- Michael Goldberg Board Member
- Peter Maag Board Member
- R. Bryan Riggsbee Board Member
- Suresh Gunasekaran Board Member
- William A. Hagstrom Board Member
Key facts
CIK
1217234
CUSIP
14167L103
13F (30d)
63 filings
62 filers
Visit website
Investor relations